Quick Takeaways
- WELLINGTON MANAGEMENT GROUP LLP filed SCHEDULE 13G/A for Apogee Therapeutics, Inc. Common Stock (APGE).
- Disclosed ownership: 8.7%.
- Date of event: 31 Dec 2025.
WELLINGTON MANAGEMENT GROUP LLP - 31 Dec 2025 SCHEDULE 13G/A Report for Apogee Therapeutics, Inc. Common Stock (APGE)
- Filing Manager
- WELLINGTON MANAGEMENT GROUP LLP
- Reporting Manager
- Wellington Management Group LLP
- Symbol
- APGE
- Shares outstanding
- 54,558,448 shares
- Disclosed Ownership
- 4,746,585 shares
- Ownership
- 8.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Feb 2026, 11:23:20 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 05 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"WELLINGTON MANAGEMENT GROUP LLP disclosed 8.7% ownership in Apogee Therapeutics, Inc. Common Stock (APGE) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 05 Aug 2025.
- Current filing was accepted on 10 Feb 2026, 11:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 8.7% | 4,746,585 | 0 | 4,341,936 | Taisia Lowe | Regulatory Analyst | |
| Wellington Group Holdings LLP | 8.7% | 4,746,585 | 0 | 4,341,936 | Taisia Lowe | Regulatory Analyst | |
| Wellington Investment Advisors Holdings LLP | 8.7% | 4,746,585 | 0 | 4,341,936 | Taisia Lowe | Regulatory Analyst | |
| Wellington Management Company LLP | 8.3% | 4,746,585 | 0 | 4,318,971 | Taisia Lowe | Regulatory Analyst |